Functional Mesoporous Silica Nanoparticles with a Core-Shell Structure for Controllable Drug Delivery - Advanced Bioactive Inorganic Materials for Bone Regeneration and Drug Delivery - page 77

Gai S., Yang P., Li C., et al. 2010. Synthesis of magnetic, up-conversion luminescent,
and mesoporous core-shell structured nanocomposites as drug carriers. Adv.
Funct. Mater. 20: 1166-1172.
Gai S., Yang P., Ma P. A., et al. 2011. Fibrous-structured magnetic and mesoporous
Fe3O4/silica microspheres: Synthesis and intracellular doxorubicin delivery. J.
Mater. Chem. 21: 16420-16426.
Gan Q., Lu X., Yuan Y., et al. 2011. A magnetic, reversible pH-responsive nanogated
ensemble based on Fe3O4 nanoparticles-capped mesoporous ilica. Biomaterials
32: 1932-1942.
Gao Q., Xu Y., Wu D., et al. 2009. pH-responsive drug release from polymer-coated
mesoporous silica spheres. J. Phys. Chem. C 113: 12753-12758.
Giri S., Trewyn B. G., Stellmaker M. P., et al. 2005. Stimuli-responsive controlled
release delivery system based on mesoporous silica nanorods capped with mag-
netic nanoparticles. Angew. Chem. Int. Ed. 44: 5038-5044.
Goldys E. M., Tomsia K. D., Jinjun S., et al. 2006. Optical characterization of Eu-doped
and undoped Gd 2 O 3 nanoparticles synthesized by the hydrogen flame pyrolysis
method. J. Am. Chem. Soc. 128: 14498-14505.
He Q., and Shi J. 2011. Mesoporous silica nanoparticle based nano drug delivery sys-
tems: Synthesis, controlled drug release and delivery, pharmacokinetics and
biocompatibility. J. Mater. Chem. 21: 5845-5855.
He Q., Shi J., Cui X., et al. 2009. Rhodamine B-co-condensed spherical SBA-15
nanoparticles: Facile co-condensation synthesis and excellent fluorescence fea-
tures. J. Mater. Chem. 19: 3395-3403.
He Q., Shi J., Zhu M., et al. 2010. The three-stage in vitro degradation behavior of mes-
oporous silica in simulated body fluid. Micropor. Mesopor. Mater. 131: 314-320.
He Q., Zhang J., Chen F., et al. 2010. An anti-ROS/hepatic fibrosis drug delivery
system based on salvianolic acid B loaded mesoporous silica nanoparticles.
Biomaterials 31: 7785-7796.
He Q., Zhang J., Shi J., et al. 2010. The effect of PEGylation of mesoporous silica
nanoparticles on nonspecific binding of serum proteins and cellular responses.
Biomaterials 31: 1085-1092.
He Q., Zhang Z., Gao F., et al. 2011. In vivo biodistribution and urinary excretion of
mesoporous silica nanoparticles: Effects of particle size and PEGylation. Small
7: 271-280.
He Q., Zhang Z., Gao Y., et al. 2009. Intracellular localization and cytotoxicity of
spherical mesoporous silica nano- and microparticles. Small 5: 2722-2729.
Hirsch L. R., Stafford R. J., Bankson J. A., et al. 2003. Nanoshell-mediated near-infra-
red thermal therapy of tumors under magnetic resonance guidance. Proc. Natl.
Acad. Sci. USA 100: 13549-13554.
Hong C.-Y., Li X., and Pan C.-Y. 2008. Smart core-shell nanostructure with a meso-
porous core and a stimuli-responsive nanoshell synthesized via surface revers-
ible addition-fragmentation chain transfer polymerization. J. Phys. Chem. C 112:
15320-15324.
Hu X., Zrazhevskiy P., and Gao X. 2009. Encapsulation of single quantum dots with
mesoporous silica. Ann. Biomed. Eng. 37: 1960-1966.
Huang D. M., Hung Y., Ko B. S., et al. 2005. Highly efficient cellular labeling of meso-
porous nanoparticles in human mesenchymal stem cells: Implication for stem
cell tracking. FASEB J. 19: 2014-2016.